SPI ex SLI

SPI ex SLI handeln
5.440,38 PKT +10,07 PKT +0,19 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

ISIN CH0033051423


Analysen zu SPI ex SLI-Werten

Datum Rating Analyst
11.01.11 Tecan (N) buy Vontobel Research
11.01.11 Lindt hold Vontobel Research
11.01.11 Bell hold Vontobel Research
11.01.11 Barry Callebaut kaufen Die Actien-Börse
10.01.11 Clariant hold Citigroup Corp.
07.01.11 Orior hold Vontobel Research
07.01.11 Bell hold Vontobel Research
04.01.11 Jungfraubahn hold Vontobel Research
03.01.11 Galenica hold Vontobel Research
28.12.10 Burckhardt Compression hold Vontobel Research
27.12.10 Bucher Industries buy Vontobel Research
22.12.10 BB Biotech kaufen Independent Research GmbH
22.12.10 Newron PharmaceuticalsAz. buy Vontobel Research
22.12.10 Dätwyler buy Vontobel Research
21.12.10 Swiss Prime Site hold Vontobel Research
21.12.10 Huber + Suhner hold Vontobel Research
17.12.10 Kudelski buy Vontobel Research
16.12.10 Helvetia Baloise buy Vontobel Research
17.12.10 BB Biotech kaufen Hamburger Sparkasse AG (Haspa)
16.12.10 Mikron hold Vontobel Research
15.12.10 Helvetia Baloise buy Vontobel Research
14.12.10 Jungfraubahn hold Vontobel Research
10.12.10 Helvetia Baloise buy Vontobel Research
08.12.10 Emmi hold Vontobel Research
08.12.10 INFICON buy Vontobel Research
03.12.10 Feintool International hold Vontobel Research
03.12.10 Emmi hold Vontobel Research
02.12.10 dormakaba hold Vontobel Research
02.12.10 Burckhardt Compression hold Vontobel Research
02.12.10 METALL ZUG buy Vontobel Research
01.12.10 Helvetia Baloise buy Vontobel Research
01.12.10 mobilezone hold Vontobel Research
01.12.10 Galenica buy Vontobel Research
30.11.10 Tecan (N) buy Vontobel Research
30.11.10 Basilea Pharmaceutica hold Vontobel Research
29.11.10 DOTTIKON ES reduce Vontobel Research
29.11.10 Basilea Pharmaceutica hold Vontobel Research
29.11.10 ARYZTA buy Vontobel Research
26.11.10 DOTTIKON ES reduce Vontobel Research
26.11.10 Basilea Pharmaceutica hold Vontobel Research